Tag: Human Papillomavirus (HPV)
Oncogenic Oral HPV DNA Detected in 3.5 Percent of Adults
Prevalence of oncogenic oral HPV higher in men, rises with number of lifetime oral sexual partners
Prevalence of Oral HPV Infection Higher for U.S. Men
Overall prevalence 11.5 percent in men, 3.2 percent in women; high-risk HPV also more prevalent in men
HPV Vaccination After Lesion Treatment Is Likely Cost-Effective
Adjuvant HPV vaccination could reduce anal cancer risk in HIV-infected men who have sex with men
ASTRO: Aggressive Reduction of Radiation Beneficial in OPSCC
In HPV-related disease, the approach linked to high cure rates, reduced side effects
USPSTF Backs Cervical Cancer Screening With Cytology or hrHPV
Recommendations for screening with cytology alone every three years or hrHPV testing every five years
Vaccine-Type HPV Rates Down for Unvaccinated Young Women
Significant decrease among unvaccinated women aged 18 to 26 years from 2009-2010 to 2013-2014
CDC: More U.S. Teens Starting HPV Vaccination
60.4 percent received one or more doses in 2016, but many not completing series
Better Prognosis With Surgery for HPV-Linked Oropharyngeal SCC
Higher survival seen for patients in low-risk category versus intermediate-, high-risk groups
Risk of HPV-Linked Second Cancers Up After Anal Cancer
Men have higher standardized incidence ratio than women for second primary malignancy
Factors Predictive of Parental Intent to Vaccinate Against HPV
Maternal education, Hispanic ethnicity, provider recommendation linked to intent to vaccinate teens
